SPDR
"Janet Yellen caught a barrage of criticism after she specifically called out the biotech sector in July, indicating it was a representative of excessive risk taking in securities investments today. The Fed release stated specifically,"valuation metrics in some sectors do appear substantially stretched--particularly those for smaller firms in the social media and biotechnology industries…"
